FDA — authorised 13 September 1979
- Marketing authorisation holder: WYETH AYERST
- Status: approved
🇺🇸 Ciclacillin in United States
FDA authorised Ciclacillin on 13 September 1979
Marketing authorisations
FDA — authorised 4 May 1988
- Application: ANDA062895
- Marketing authorisation holder: TEVA
- Local brand name: CYCLACILLIN
- Indication: TABLET — ORAL
- Status: approved
Ciclacillin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Ciclacillin approved in United States?
Yes. FDA authorised it on 13 September 1979; FDA authorised it on 4 May 1988.
Who is the marketing authorisation holder for Ciclacillin in United States?
WYETH AYERST holds the US marketing authorisation.